Shares of Novavax jumped after the biotech company said its new Covid vaccine generated a broad immune response against the now-dominant Eris variant and another fast-spreading strain of the virus in ...

A new Covid-19 vaccine from Novavax was 89% effective and appeared to offer protection against some variants of the coronavirus in a clinical trial conducted in the UK, the American biotech firm has ...

Add Yahoo as a preferred source to see more of our stories on Google. Novavax, sold under the brand name Nuvaxovid, is a protein-based COVID-19 vaccine — the same technology used to develop many other ...

This week the FDA approved an updated version of a COVID-19 vaccine from Novavax. This shot is effective at preventing infection with Omicron strains of the virus. For some, the Novavax vaccine may ...

Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the vaccine wasn't... Novavax COVID-19 Vaccine Effective, But Less So ...

Novavax says its COVID-19 vaccine appears 89% effective, based on early findings from a British study. According to USA Today, the two-dose vaccine was just 60% effective in the South African trial.

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts of the ...

The U.S. just approved the updated non-mRNA COVID-19 vaccine made by Novavax for use and millions of doses are already being distributed across the country. “Novavax’s authorization today means people ...